Helus Pharma Inc.(HELP)

Medical - Pharmaceuticals · Toronto, ON

$10.99-0.43 (-3.77%)

Delayed quote: Oct 6, 2026, 12:15 PM EDT

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T16:17:03.039Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:17:03.039Z.

Quote observation: 2026-10-06T16:15:14.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 681,205,259
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 166,165,362
TTM operating income · period ending 2026-06-30: -177,170,375

FMP input reference: 934548bd97ab8c390298f716fcf622fc2d1107cfab085c47b2b47650fd31fbc6

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

HELP EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

HELP Competitors' EV/EBIT Ratio

HELP

Helus Pharma Inc.

Current

Market Cap

$681.21M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ANNX

Annexon, Inc.

vs HELP

Market Cap

$681.58M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AVR

Anteris Technologies Global Corp.

vs HELP

Market Cap

$690.28M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FDMT

4D Molecular Therapeutics, Inc.

vs HELP

Market Cap

$672.27M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDXG

MiMedx Group, Inc.

vs HELP

Market Cap

$669.77M

EV/EBIT Ratio

61.19x

TTM Avg

21.67x

3Y Avg

25.85x

5Y Avg

35.25x

OABI

OmniAb, Inc.

vs HELP

Market Cap

$648.75M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OLMA

Olema Pharmaceuticals, Inc.

vs HELP

Market Cap

$714.33M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COLL

Collegium Pharmaceutical, Inc.

vs HELP

Market Cap

$718.54M

EV/EBIT Ratio

9.13x

TTM Avg

12.78x

3Y Avg

12.26x

5Y Avg

15.40x

AVBP

ArriVent BioPharma, Inc.

vs HELP

Market Cap

$659.73M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AVTX

Avalo Therapeutics, Inc.

vs HELP

Market Cap

$717.52M

EV/EBIT Ratio

N/A

TTM Avg

877.08x

3Y Avg

871.89x

5Y Avg

871.89x

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Helus Pharma Inc. (HELP)	$681.21M	N/A	N/A	N/A	N/A
Annexon, Inc. (ANNX)vs ›	$681.58M	N/A	N/A	N/A	N/A
Anteris Technologies Global Corp. (AVR)vs ›	$690.28M	N/A	N/A	N/A	N/A
4D Molecular Therapeutics, Inc. (FDMT)vs ›	$672.27M	N/A	N/A	N/A	N/A
MiMedx Group, Inc. (MDXG)vs ›	$669.77M	61.19x	21.67x	25.85x	35.25x
OmniAb, Inc. (OABI)vs ›	$648.75M	N/A	N/A	N/A	N/A
Olema Pharmaceuticals, Inc. (OLMA)vs ›	$714.33M	N/A	N/A	N/A	N/A
Collegium Pharmaceutical, Inc. (COLL)vs ›	$718.54M	9.13x	12.78x	12.26x	15.40x
ArriVent BioPharma, Inc. (AVBP)vs ›	$659.73M	N/A	N/A	N/A	N/A
Avalo Therapeutics, Inc. (AVTX)vs ›	$717.52M	N/A	877.08x	871.89x	871.89x

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBIT Ratio: N/A

HELP EV/EBIT Ratio Metrics

HELP Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

Related Metrics